Super-Enhancer-Driven RAE1 Shows Higher Protein Levels in Tumor Compared to Adjacent Nonmalignant Stroma in High-Grade Serous Ovarian Cancer Patients

Reprod Sci. 2023 Aug;30(8):2397-2400. doi: 10.1007/s43032-023-01199-8. Epub 2023 Feb 21.

Authors

Caglar Berkel¹, Ercan Cacan²

Affiliations

¹ Department of Molecular Biology and Genetics, Tokat Gaziosmanpasa University, Tokat, Turkey. caglar.berkel@gop.edu.tr.
² Department of Molecular Biology and Genetics, Tokat Gaziosmanpasa University, Tokat, Turkey. ercan.cacan@gop.edu.tr.

PMID: 36810690
DOI: 10.1007/s43032-023-01199-8

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / metabolism
Cystadenocarcinoma, Serous* / pathology
Female
Humans
Nuclear Matrix-Associated Proteins / metabolism
Nucleocytoplasmic Transport Proteins
Ovarian Neoplasms* / pathology

Substances

Biomarkers, Tumor
RAE1 protein, human
Nucleocytoplasmic Transport Proteins
Nuclear Matrix-Associated Proteins